Cargando…
Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery
OBJECTIVE: Mitochondrial diseases are a group of devastating disorders for which there is no transformative cure. The majority of therapies for mitochondrial disease—approved, previously tested, or currently in development—are small molecules. The implementation of better cell-based models of mitoch...
Autores principales: | Chin, Randall Marcelo, Panavas, Tadas, Brown, Jeffrey M., Johnson, Krista K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870301/ https://www.ncbi.nlm.nih.gov/pubmed/29587845 http://dx.doi.org/10.1186/s13104-018-3297-6 |
Ejemplares similares
-
Limitations of lymphoblastoid cell lines for functional analysis of SNPs
por: Pathak, Hansi, et al.
Publicado: (2017) -
Genetic and genomic stability across lymphoblastoid cell line expansions
por: Scheinfeldt, Laura B., et al.
Publicado: (2018) -
The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023) -
The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023) -
Nascent transcription upon interferon-α2 stimulation on human and rhesus macaque lymphoblastoid cell lines
por: Ramirez, Daniel, et al.
Publicado: (2023)